Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2022 Sep 3:1. Online ahead of print. doi: 10.1007/s11030-022-10521-6

Retraction Note: CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy

Amgad M Rabie 1,2,3,
PMCID: PMC9440450  PMID: 36057028

Retraction Note: Molecular Diversity (2021) 25:1839–1854 10.1007/s11030-020-10169-0

The Editors-in-Chief have retracted this article because the results presented have been published previously in [1] and the article is therefore redundant. The author does not agree with this retraction.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Rabie AM. Two antioxidant 2,5-disubstituted-1,3,4-oxadiazoles (CoViTris2020 and ChloViD2020): successful repurposing against COVID-19 as the first potent multitarget anti-SARS-CoV-2 drugs. New J Chem. 2021;45:761. doi: 10.1039/D0NJ03708G. [DOI] [Google Scholar]

Articles from Molecular Diversity are provided here courtesy of Nature Publishing Group

RESOURCES